The Stem Cell Summit Webcast Full Agenda
>Click hereto view the Free Executive Summary
Welcome and meeting overview | Industry Overview
David Scadden, HSCI and MGH
Bernard Siegel, Genetics Policy Institute
G. Steven Burrill, CEO, Burrill and Company
How Stem Cell Research Will Transform Medicine in the 21 Century
A discussion of why stem cell research holds vast promise and the experiments that are taking place that have researchers excited and hopeful for the future of healthcare.
The perspective of basic research and biology
Douglas Melton, HSCI and Harvard
John Gearhart, Johns Hopkins
The perspective of clinical applications
Lawrence Goldstein, University of California San Diego Stem Cell Program
Leonard Zon, HSCI and Children’s Hospital Boston
Moderator: Brock Reeve
Keynote Presentation: Stem Cell Research: A Patient’s Perspective
Brooke Ellison, President and Founder, The Brooke Ellison Project and BrookePAC:
Keynote Presentation: A Case Study of Private Philanthropic Support for Stem
Cell Research and Advocacy: The Stowers Medical Research Organizations
William B. Neaves, PhD, President and Chief Executive Officer, Stowers Institute for
Medical Research
Introduced by Steve Hyman, Provost, Harvard University
Panel Discussion: The Promise of SCNT and Reprogramming
Leading researchers will review the work currently being performed in their labs and will discuss the state of this polemical field of research.
George Daley, HSCI and Children’s Hospital Boston
Ian Wilmut, University of Edinburgh
Rudolf Jaenisch, MIT
Kevin Eggan, HSCI and Harvard
Moderator: George Daley
Panel Discussion: The Global Perspective on Stem Cell Research
A review of research, policy and advocacy efforts from around the globe.
Christine Mummery, Netherlands, HSCI Radcliffe Fellow
Stephen Livesey, Australia
Janet Rossant, Canada
Raphael Hofstein, Hadasit
Moderator: Fiona Murray, MIT Sloan School of Management
Panel Discussion: Stem Cell Nation
Officials from different states will profile efforts they have taken to craft economic and legislation incentives for stem cell research.
Senator Jeff Wentworth (R-San Antonio)
Donn Rubin, Chairman, Missouri Coalition for Cures
Susan Solomon, CEO, New York Stem Cell Foundation
Salvatore DiMasi, Speaker of the House of Representatives, MA (invited)
Moderator: Kevin Casey, Senior Director of Federal and State Relations, Harvard University
Panel Discussion: The Hospital Perspective-An HSCI Case Study
A case study examining the HSCI working model of interorganizational collaboration in stem cell research. What works well and what doesn’t? Implications for other research and health care organizations and what this means for health care in the future.
Peter Slavin, CEO, MGH
James Mandell, CEO, Children’s Hospital Boston
Ed Benz, CEO, Dana Farber Cancer Institute
Paul Levy, CEO, Beth Israel Deaconess Medical Center
Gary Gottlieb, CEO, Brigham and Women’s Hospital
Moderator: David Scadden, HSCI and MGH
Panel Discussion: Investing in Stem Cell Research – the VC Perspective
A panel of VC’s will discuss business models and creative financing strategies for this nascent science.
Beth Seidenberg, Kleiner Perkins Caufield and Byers
Greg Bonfiglio, Proteus Venture Partners
Doug Fambrough, Oxford Bioscience Partners
Moderator: G. Steven Burrill, Burrill & Co.
Panel Discussion: Investing in Stem Cell Research – the Biotechnology Perspective
A panel of biopharma and biotech executives will discuss business models and investment incentives.
John McNeish, Pfizer
Glenn Begley, Amgen
Al Sandrock, Biogen Idec
Steve Oesterle, Medtronic
Moderator: William Sahlman, Harvard Business School
Panel Discussion: Taking Research from the Labs to the Clinic: Legal, Translational and Regulatory Challenges for Stem Cell Companies
Experts will address the intellectual property, translational and regulatory challenges impacting the development of stem cell products and propose solutions to advance commercial applications.
S. Peter Ludwig, Darby & Darby
Mark Ellinger, Fish & Richardson
Annemarie Moseley, CEO, Aggregate Therapeutics
Pedro Huertas, Chief Development Officer, Advanced Cell Technology
Moderator: Frances Toneguzzo, PhD, Director, Corporate Sponsored Research & Licensing, Massachusetts General Hospital
Balancing Global Regulation to Enhance Global Collaboration
Carefully crafted global regulations should encourage, rather than hinder, global collaborative efforts.
Niels Geijsen, Massachusetts General Hospital
Doug Sipp, Riken Center for Developmental Biology; Chair, International Committee, ISSCR
Joseph Fuller, Monitor Group
Moderator: Pearl O’Rourke, Partners HealthCare System
